Clinical Trial

Aveir VR Real-World Evidence Post-Approval Study

NCT: NCT05270499 · ACTIVE_NOT_RECRUITING

NCT IDNCT05270499

StatusACTIVE_NOT_RECRUITING

Start Date2022-06-21

Completion2034-09-30

SponsorAbbott Medical Devices (INDUSTRY)

First posted2022-03-08

Last updated2026-05-20

Brief Summary

The purpose of this post-approval study is to evaluate the long-term safety of the single-chamber Aveir VR leadless pacemaker using real-world evidence methods.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.